Also categorized in Global Health:
National 3-Digit Emergency Number for Mental Health Crises to Be Launched
x hide permanently

Ground Breaking COVID-19 Study Shows Umbilical-Cord Derived Mesenchymal Stem Cells Reduce Risk of Death & Quicken Time to Recovery

Daily clinical news

hospimedica.com

A unique and groundbreaking randomized controlled trial has shown that umbilical cord-derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest COVID-19 patients.

Researchers from the University of Miami (Coral Gables, FL, USA) who led the study believe that treating COVID-19 with mesenchymal stem cells makes sense. Mesenchymal cells not only help correct immune and inflammatory responses that go awry, they also have antimicrobial activity and have been shown to promote tissue regeneration. When given intravenously, mesenchymal stem cells migrate naturally to the lungs. That's where therapy is needed ...